Ritter Pharmaceuticals Company
.png)
Ritter Pharmaceuticals discovers and commercializes treatments for gastrointestinal diseases.
Total Funding:
25730038
Headquarters:
Greater Los Angeles Area, West Coast, Western US
Funding Status:
IPO
Employee Number:
11-50
Estimated Revenue:
Less than $1M
Investment Stage:
N/A
Last Funding Type:
Post-IPO Equity
Number Of Exists:
N/A
Technology:
Anti-infective Drugs
Investor Type:
N/A
Last Funding Date:
2015
Founded Date:
2004-01-01
Industry:
Biotechnology, Clinical Trials, Health Diagnostics, Medical, PharmTech, Pharmaceutical, Robotics